EIGER BIOPHARMACEUTICALS

Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.

EIGER BIOPHARMACEUTICALS

Social Links:

Industry:

Biotechnology Health Care Medical

Founded:

2008-01-01

Address:

San Carlos, California, United States

Country:

United States

Website Url:

http://www.eigerbio.com

Total Employee:

11+

Status:

Active

Contact:

(650)272-6138

Email Addresses:

[email protected]

Total Funding:

156.26 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome

Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

Current Advisors List

paul-f-truex_image

Paul F. Truex Observer @ Eiger BioPharmaceuticals
Board_observer

edgar-g-engleman_image

Edgar G. Engleman Director and Managing Partner @ Eiger BioPharmaceuticals
Board_member

nina-kjellson_image

Nina Kjellson Board Member @ Eiger BioPharmaceuticals
Board_member

Current Employees Featured

not_available_image

Curtis Scribner
Curtis Scribner Vice President, Regulatory @ Eiger BioPharmaceuticals
Vice President, Regulatory

not_available_image

Henk Kocken
Henk Kocken Vice President Quality Assurance @ Eiger BioPharmaceuticals
Vice President Quality Assurance
2021-01-01

not_available_image

Jeffrey Glenn
Jeffrey Glenn Director, Founder @ Eiger BioPharmaceuticals
Director, Founder

christopher-kurtz_image

Christopher Kurtz
Christopher Kurtz Chief Technical Officer @ Eiger BioPharmaceuticals
Chief Technical Officer
2022-04-01

david-cory_image

David Cory
David Cory President and Chief Executive Officer, Board Director @ Eiger BioPharmaceuticals
President and Chief Executive Officer, Board Director

not_available_image

Erik Atkisson
Erik Atkisson General Counsel & Chief Compliance Officer @ Eiger BioPharmaceuticals
General Counsel & Chief Compliance Officer
2021-01-01

not_available_image

Shelly Xiong
Shelly Xiong Vice President, Regulatory Affairs @ Eiger BioPharmaceuticals
Vice President, Regulatory Affairs

kevin-kaster_image

Kevin Kaster
Kevin Kaster Vice President, Patents and Licensing @ Eiger BioPharmaceuticals
Vice President, Patents and Licensing

sarah-mathieson_image

Sarah Mathieson
Sarah Mathieson Senior Vice President, Head of Corporate Affairs @ Eiger BioPharmaceuticals
Senior Vice President, Head of Corporate Affairs
2022-04-01

not_available_image

Ingrid Choong
Ingrid Choong Sr. VP, Clinical Development & Operations @ Eiger BioPharmaceuticals
Sr. VP, Clinical Development & Operations
2019-01-01

Founder

not_available_image

Jeffrey Glenn

Stock Details

Company's stock symbol is NASDAQ:EIGR

Acquisitions List

Date	Company	Article	Price
2015-11-18	Celladon	Celladon acquired by Eiger BioPharmaceuticals	N/A

Investors List

innovatus-capital-partners_image

Key Employee Changes

Date	New article
2022-04-18	Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments
2021-09-21	Eiger BioPharmaceuticals Appoints Erik Atkisson as General Counsel and Chief Compliance Officer

Official Site Inspections

http://www.eigerbio.com Semrush global rank: 2.28 M Semrush visits lastest month: 8.31 K

Host Informations
Whois Informations

Loading ...